Intragastric administration of attenuated Salmonella typhimurium harbouring transmissible gastroenteritis virus (TGEV) DNA vaccine induced specific antibody production

Vaccine

Volumn 27, Issue 37, 2009, Pages 5035-5040

  Yang, Heng ^a   Cao, Sanjie ^a   Huang, Xiaobo ^a   Liu, Jiawen ^a   Tang, Ying ^a   Wen, Xintian ^a  

^a Key Laboratory of Animal Disease and Human Health of Sichuan Province   (China)

Author keywords

Attenuated Salmonella typhimurium; DNA vaccine; Oral immunization; S gene; Transmissible gastroenteritis virus

Indexed keywords

ANTIVIRUS AGENT; DNA VACCINE; UNCLASSIFIED DRUG; VIRUS VACCINE; VIRUS VACCINE PVAX S;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG DOSE COMPARISON; ELECTROPORATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPRESSION VECTOR; EXPRESSION VECTOR PVAX1; FEMALE; GENE AMPLIFICATION; GLYCOPROTEIN SYNTHESIS; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALMONELLA TYPHIMURIUM; SALMONELLA TYPHIMURIUM SL7207; TRANSMISSIBLE GASTROENTERITIS VIRUS;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, VIRAL; ANTIBODY FORMATION; FEMALE; MICE; MICE, INBRED BALB C; PLASMIDS; SALMONELLA TYPHIMURIUM; TRANSMISSIBLE GASTROENTERITIS VIRUS; VACCINES, ATTENUATED; VACCINES, DNA; VIRAL PROTEINS; VIRAL VACCINES;

EID: 67650762187     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.06.050     Document Type: Article

References (35)

1. In: Leman A.D., Straw B.E., Mengeling W.L., and Taylor D.J. (Eds). Diseases of swine. 8th ed. (1999), Iowa State University Press, Ames
2. Laude H., Rasschaert D., Delmas B., Godet M., Gelfi J., and Charley B. Molecular biology of transmissible gastroenteritis virus. Vet Microbiol 23 (1990) 147-154
3. Delmas B.J., Gelfi R.L., Haridon L.K., L'Haridon R., Vogel L.K., Sjostrom H., et al. Aminopeptidase N is a major receptor for the enteropathogenic coronavirus TGEV. Nature 357 (1992) 417-420
4. Jimenez G., Correa I., Melgosa M.P., Bullido M.J., and Enjuanes L. Critical epiptopes in transmissible gastroenteritis virus neutralization. J Virol 60 1 (1986) 131-139
5. Delmas B.J., Rasschaert D., Godet M., Gelfi J., and Laude H. Four major antigenic sites of the coronavirus transmissible gastroenteritis virus are located on the amino-terminal half of spike glycoprotein S. J Gen Virol 71 Pt 6 (1990) 1313-1323
6. Tuboly T., Nagy E., Dennis J.R., and Derbyshire J.B. Immunogenicity of the S protein of transmissible gastroenteritis virus expressed in baculovirus. Arch Virol 137 1-2 (1994) 55-67
7. Saif L.J. Mucosal immunity: an overview and studies of enteric and respiratory coronavirus infections in a swine model of enteric disease. Vet Immunol Immunopathol 54 1-4 (1996) 163-169
8. Saif L.J., van Cott J.L., and Brim T.A. Immunity to transmissible gastroenteritis virus and porcine respiratory coronavirus infections in swine. Vet Immunol Immunopathol 43 1-3 (1994) 89-97
9. Smerdou C., Urniza A., Curtis R., and Enjuanes L. Characterization of transmissible gastroenteritis coronavirus S protein expression products in avirulent S. typhimurium delta cya delta crp: persistence, stability and immune response in swine. Vet Microbiol 48 1-2 (1996) 87-100
10. Smerdou C., Anton I.M., Plana J., Curtiss R., and Enjuanes L. A continuous epitope from transmissible gastroenteritis virus S protein fused to E. coli heat-labile toxin B subunit expressed by attenuated Salmonella induces serum and secretory immunity. Virus Res 41 1 (1996) 1-9
11. Huaiqing C., and Schifferli D.M. Enhanced immune responses to viral epitopes by combining macrophage-inducible expression with multimeric display on a Salmonella vector. Vaccine 19 20-22 (2001) 3009-3018
12. Ho P.S., Kwang J., and Lee Y.K. Intragastric administration of Lactobacillus casei expressing transmissible gastroentritis coronavirus spike glycoprotein induced specific antibody production. Vaccine 23 11 (2005) 1335-1342
13. Gomez N., Carrillo C., Salinas J., Parra F., Borca M.V., and Escribano J.M. Expression of immunogenic glycoprotein S polypeptides from transmissible gastroenteritis coronavirus in transgenic plants. Virology 249 2 (1998) 352-358
14. Streatfield S.J., Jilka J.M., Hood E.E., Turner D.D., Bailey M.R., Mayor J.M., et al. Plant-based vaccines: unique advantages. Vaccine 19 17-19 (2001) 2742-2748
15. Lamphear B.J., Streatfield S.J., Jilka J.M., Brooks C.A., Barker D.K., Turner D.D., et al. Delivery of subunit vaccines in maize seed. J Control Rel 85 (2002) 169-180
16. Lamphear B.J., Jilka J.M., Kesl L., Welter M., Howard J.A., and Streatfield S.J. A corn-based delivery system for animal vaccines: an oral transmissible gastroenteritis virus vaccine boosts lactogenic immunity in swine. Vaccine 22 19 (2004) 2420-2424
17. Tuboly T., Yu W., Bailey A., Degrandis S., Du S., Erickson L., et al. Immunogenicity of porcine transmissible gastroenteritis virus spike protein expressed in plants. Vaccine 18 19 (2000) 2023-2028
18. Nilesh P.T., and Michael P.T. Recent developments in the use of transgenic plants for the production of human therapeutics and biopharmaceuticals. Plant Cell 79 2 (2004) 125-145
19. Hu S., Bruszewski J., Smalling R., and Browne J.K. Studies of TGEV spike protein gp195 expressed in E. coli and by a TGEV-vaccinia virus recombinant. Adv Exp Med Biol 185 (1985) 63-82
20. Schoen C., Stritzker J., Goebel W., and Pilgrim S. Bacteria as DNA vaccine carriers for genetic immunization. Int J Med Microbiol 294 (2004) 319-335
21. Medina E., and Guzman C.A. Use of live bacterial vaccine vectors for antigen delivery: potential and limitations. Vaccine 19 13-14 (2001) 1572-1580
22. Dietrich G., Kolb-Maurera A., Spreng S., Schartl M., Goebel W., and Gentschev I. Gram-positive and Gram-negative bacteria as carrier systems for DNA vaccines. Vaccine 19 17-19 (2001) 2506-2512
23. Mohamed T.S., Marvin S.R., Anthony L.D., George K.L., and David M.H. Mucosal and systemic HIV-1 Env-specific CD8+ T-cells develop after intragastric vaccination with a Salmonella Env DNA vaccine vector. Vaccine 20 3-4 (2002) 623-629
24. Woo P.C., Wong L.P., Zheng B.J., and Yuen K.Y. Unique immunogenicity of hepatitis B virus DNA vaccine presented by live-attenuated Salmonella typhimurium. Vaccine 19 (2001) 2945-2954
25. Flo J., Tisminetzky S., and Baralle F. Oral transgene vaccination mediated by attenuated Salmonellae is an effective method to prevent Herpes simplex virus-2 induced disease in mice. Vaccine 19 20-22 (2001) 1772-1782
26. Pan Z.M., Jiao X.N., Huang J.L., Yin Y.L., and Tang L.H. Safety and efficacy of attenuate Salmonella typhimurium harbouring DNA vaccine against Newcastle disease virus. Acta Microbiol Sin 45 6 (2005) 937-941 (in Chinese with English abstract)
27. Li L., Fang W., Li J., Huang Y., and Yu L. Oral DNA vaccination with the polyprotein gene of infectious bursal disease virus (IBDV) delivered by attenuated Salmonella elicits protective immune responses in chickens. Vaccine 24 33-34 (2006) 5919-5927
28. Jiang P., Jiang W., Li Y., Wu S., and Xu J. Humoral immune response induced by oral administration of S. typhimurium containing a DNA vaccine against porcine reproductive and respiratory syndrome virus. Vet Immunol Immunopathol 102 3 (2004) 321-328
29. Qu D., Wang S., Cai W., and Du A. Protective effect of a DNA vaccine delivered in attenuated Salmonella typhimurium against Toxoplasma gondii infection in mice. Vaccine 26 35 (2008) 4541-4548
30. Darji A., Lage Sz., Garbe A.I., Chakraborty T., and Weiss S. Oral delivery of DNA vaccines using attenuated Salmonella typhimurium as carrier. FEMS Immunol Med Microbiol 27 (2000) 341-349
31. Weiss S. Transfer of eukaryotic expression plasmids to mammalian hosts by attenuated Salmonella spp. Int J Med Microbiol 293 1 (2003) 95-106
32. Marcela F.P., Myron M.L., and Marcelo B.S. Animal models paving the way for clinical trials of attenuated Salmonella enterica serovar Typhi live oral vaccines and live vectors. Vaccine 21 5-6 (2003) 401-418
33. Lintermans P., and Greve H.D. Live bacterial vectors for mucosal immunization. Adv Drug Deliv Rev 18 (1995) 73-89
34. Anton I.M., Gonzalez S., Bullido M.J., Corsin M., Risco C., and Langeveld J.P. Cooperation between transmissible gastroenteritis coronavirus (TGEV) structural proteins in the in vitro induction of virus-specific antibodies. Virus Res 46 1-2 (1996) 111-124
35. al-Ramadi B.K., Adeghate E., Mustafa N., Ponery A.S., and Fernandez-Cabezudo M.J. Cytokine expression by attenuated intracellular bacteria regulates the immune response to infection: the Salmonella model. Mol Immunol 38 12-13 (2001) 931-940